Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Thrombocytopenia”

404 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 404 results

Testing effectiveness (Phase 2)Looking for participantsNCT06799611
What this trial is testing

An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)Treatment
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Study completedNCT05279872
What this trial is testing

Zanubrutinib in Patients With ITP

Who this might be right for
Immune ThrombocytopeniaBruton Tyrosine Kinase
Peking University People's Hospital 20
Not applicableNot Yet RecruitingNCT07014904
What this trial is testing

"Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Thrombocytopenic Purpura in Children"

Who this might be right for
ITP - Immune Thrombocytopenia
Sohag University 80
Not applicableStudy completedNCT03810352
What this trial is testing

Association of Platelet Parameters With Bleeding Severity in Children With ITP

Who this might be right for
Immune Thrombocytopenia
Boston Children's Hospital 95
Testing effectiveness (Phase 2)Looking for participantsNCT06094881
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 60
Not applicableStudy completedNCT01666795
What this trial is testing

Autoantibody Specificity and Response to IVIG in ITP

Who this might be right for
Immune Thrombocytopenia (ITP)
Shandong University 672
Not applicableLooking for participantsNCT06817395
What this trial is testing

Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Massachusetts General Hospital 100
Testing effectiveness (Phase 2)Study completedNCT01880047
What this trial is testing

Safety and Efficacy of Eltrombopag at Escalated Doses

Who this might be right for
Immune ThrombocytopeniaPlatelet Disorder
Weill Medical College of Cornell University 35
Testing effectiveness (Phase 2)UnknownNCT04368598
What this trial is testing

The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 44
Testing effectiveness (Phase 2)WithdrawnNCT04039477
What this trial is testing

Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP

Who this might be right for
Autoimmune Hemolytic AnemiaImmune Thrombocytopenia
Kezar Life Sciences, Inc.
Not applicableUnknownNCT02892630
What this trial is testing

Immune Thrombocytopenia in Pregnancy

Who this might be right for
Immune ThrombocytopeniaPregnancy
Assistance Publique - Hôpitaux de Paris 300
Testing effectiveness (Phase 2)Ended earlyNCT00074165
What this trial is testing

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

Who this might be right for
Brain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/OrganLymphoma+1 more
OHSU Knight Cancer Institute 17
Large-scale testing (Phase 3)UnknownNCT03010202
What this trial is testing

The PROLONG Trial - Rituximab Maintenance Therapy in ITP

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Ostfold Hospital Trust 136
Testing effectiveness (Phase 2)Active Not RecruitingNCT05023915
What this trial is testing

Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 106
Not applicableUnknownNCT05410249
What this trial is testing

Assessment of FOXP3 Gene Polymorphisms and Serum Interleukin 10 in Patients With ITP

Who this might be right for
Thrombocytopenia
Sohag University 130
Large-scale testing (Phase 3)UnknownNCT03520049
What this trial is testing

Proof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Unity Health Toronto 30
Large-scale testing (Phase 3)Study completedNCT04516967
What this trial is testing

Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 75
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07421167
What this trial is testing

Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)Primary Evans Syndrome (ES)
Novartis Pharmaceuticals 164
Not applicableEnded earlyNCT01462916
What this trial is testing

Honey in Chronic Immune Thrombocytopenia

Who this might be right for
Chronic Thrombocytopenic Purpura
mamdouh abdulmaksoud abdulrhman 30
Large-scale testing (Phase 3)Looking for participantsNCT07007962
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

Who this might be right for
Immune Thrombocytopenia
Sanofi 60
Load More Results